MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Limb myorhythmia treated with chemodenervation: A case report

N. Saez Calveras, M. Bryarly, M. Salinas (Dallas, USA)

Meeting: 2022 International Congress

Abstract Number: 925

Keywords: Botulinum toxin: Clinical applications: other, Denervation, Myorhythmia

Category: Tremor

Objective: To describe the case of a patient with limb myorhythmia successfully treated with bolutinum toxin injections.

Background: Myorhythmia is a rare condition characterized by a repetitive, rhythmic, slow frequency (1-4 Hz) movement affecting the cranial and limb muscles.  The most common causes include stroke, demyelinating disorders, drug or toxin intake, trauma, and infections. The management of this condition is very limited with pharmacologic agents such as anticholinergics, antispasmodics, anticonvulsant or dopaminergic agents showing limited efficacy.

Method: We review relevant clinical history, laboratory values, imaging, electromyographic data, and clinical course.

Results: The patient is a 30-year-old male evaluated for abnormal movements of the left lower leg that began after an ankle injury. After a few years of persistent symptoms, the patient underwent Achilles tendon scar tissue debridement without improvement in movements. Normal neuroimaging prompted a referral to the Neurology clinic for further evaluation. On examination, he had near-constant involuntary, slow, rhythmic flexion/extension tremor of toes 2-4; there were no sensory or strength deficits, appendicular or central ataxia, or upper motor neuron signs. The movements were diminished during active movement. Needle EMG revealed a rhythmic, 2-3 Hz tremor isolated to the flexor digitorum brevis. After failure of medical management with muscle relaxants, gabapentin, and levodopa trials, the patient underwent an EMG-guided chemodenervation procedure with Incobotulinum toxin A injection on the left flexor digitorum brevis. At three months follow-up, he had achieved a sustained 40-50% reduction in the intensity of the movements and improved quality of life.

Conclusion: Myorhythmia is a rare movement disorder with a proposed central etiology. Evaluation is aided by EMG, which can also identify targets for chemodenervation in medication-refractory cases.

To cite this abstract in AMA style:

N. Saez Calveras, M. Bryarly, M. Salinas. Limb myorhythmia treated with chemodenervation: A case report [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/limb-myorhythmia-treated-with-chemodenervation-a-case-report/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/limb-myorhythmia-treated-with-chemodenervation-a-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley